Matthew Beuerlein, MD
Otolaryngology · Liberty, MONPI 1891763363
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $227 of the $376 with a category attached, or 60.4%. 9 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 26.3% of the total. Reporting peaked in 2021 at $133 and has fallen 83.6% since, to $22 in 2025. That places this record below the midpoint for otolaryngology clinicians in MO, where the typical reported total is $840.
Across 11 payments — averaging $34.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$99
- Acclarent, Inc$80
- GSK$50
- Stryker$47
- Regeneron Healthcare Solutions, Inc.$26
- KARL Storz Endoscopy-america$22
- plus $52 from 3 others
What the payments were for
- Consulting fees$5013%
- Food & beverage$22760%
- Education$9926%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Acclarent, Inc | 3 | $80 |
| GSK | 1 | $50 |
| Stryker | 1 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| KARL Storz Endoscopy-america | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $19 |
| Intersect ENT, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$376 in reported general payments places this provider in the 35th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 45 | $5,604 |
| Ipratropium Bromide | 97 | $4,842 |
| Famotidine | 180 | $4,380 |
| Omeprazole | 207 | $3,851 |
| Pantoprazole Sodium | 86 | $2,233 |
| Azelastine Hcl | 37 | $1,557 |
| Fluticasone Propionate | 72 | $1,153 |
| Methylprednisolone | 150 | $824 |
| Fluocinolone Acetonide Oil | 21 | $815 |
| Mupirocin | 42 | $430 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $371 |
| Levothyroxine Sodium | 26 | $341 |
| Cefdinir | 18 | $236 |
| Diazepam | 16 | $182 |
| Clindamycin Hcl | 11 | $168 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Liberty
- Talon ManingasJoplin$314K
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- James GouldFestus$143K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Jeffrey SharonSt. Louis$18K
- Kelvin WallsLees Summit$14K
- Cristine Klatt-CromwellSaint Louis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.